Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...

Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield ...

COVID-19 can cause a long list of health issues, including flu symptoms, respiratory problems and even organ damage, ...

Supermodel Elle Macpherson has continued to promote her controversial memoir in New York months after claiming she cured her ...

Some 10,000 patients in England are set to get their very own disease-busting jab by 2030, through the NHS Cancer Vaccine ...

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's ...

Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

COVID-19’s impact on cancer patients leads to the discovery of immune cells that may help target tumors, potentially offering ...

A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...

(Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced the ...

Medical Watch Digest for Nov 19 Diabetes increases dementia risk in adults younger than 50 There is a new warning about ...